Skip to main content

Across the health system | A question to investigate

Understand the journey after a practice makes the referral.

A referral can be appropriate in principle and still be difficult to complete in practice. Availability, communication, eligibility questions and the route back to the practice all shape what happens next. For PCNs, pharmacy service leads and commissioners, our proposed PHARMORIS use case examines referral coordination around Pharmacy First. It asks whether the local pathway can become easier to understand and review, without reducing the service to referral volume or treating community pharmacy as an unlimited spare appointment book.

Film credits

In the conversation.

NEUVIOR and our founder’s perspectives have appeared across science, business and technology publications.

University of Warwick IATL | AI Ethics NowpharmaphorumTechRadar ProET PharmaFinancial TimesPharmaceutical TechnologyPharmaTimesManufacturing ChemistDigital HealthDaily BusinessTheBusinessDesk.comStartups MagazineInsider MediaYorkshire PostYork PressBusinessCloud

Reporting, commentary, letters and podcast appearances | Read each feature for its format and source.

Distinguish routing from clinical assessment.

NHS England publishes resources for general practices referring suitable patients to Pharmacy First (NHS England, n.d.). The local workflow still needs clarity about how the referral is made, which information accompanies it and how exceptions return. Our proposed organisational analysis would not decide whether an individual needs a particular treatment. It would examine agreed administrative steps and the information staff need to use them. The pharmacist's assessment and the clinical pathway remain separate professional responsibilities, rather than an outcome inferred from a successful electronic transfer.

Follow returns as carefully as arrivals.

A referral system is incomplete if it only counts what leaves the practice. Map acknowledgement, consultation outcomes available to the referring team and the handling of people who need another route. Record repeated contacts and uncertainty about the next responsible service. Some returns are appropriate and should not be labelled failure. The analysis should help teams distinguish an avoidable coordination problem from a clinically appropriate onward decision, using definitions agreed by the professionals delivering the service.

A useful pathway view separates referrals received, consultations completed, appropriate onward referrals, people not reached and episodes whose status cannot yet be established. Agree locally which stages can be linked and how duplicate contacts are identified. Count the entire episode rather than treating every message as another patient. This gives the practice and pharmacy a shared operational language before anyone tries to estimate workload displacement or a financial consequence.

Make capacity and accessibility visible.

A pathway may work differently by time, location or the support a person needs. The proposed review would examine whether staff can find current local arrangements and explain the next step clearly. Include people who need assistance with digital communication or accessible information. Do not assume a published service listing proves that a particular appointment can be provided immediately. A useful process respects community pharmacy workload and preserves an escalation route when the intended destination cannot meet the person's needs.

Compare a practical briefing with today's resources.

An initial PHARMORIS evaluation could use approved pathway documents and synthetic referral scenarios to prepare a local coordination brief. Compare it with the existing practice and pharmacy resources, not with an artificial absence of guidance. Participants would identify the correct organisational route, necessary information and handling of exceptions. Clinical eligibility assessment would remain outside the initial task. The study would test whether the brief is accurate, usable and worth maintaining when local arrangements change.

Look beyond the referral count.

A useful handover is information that reaches someone able to act. Explore a constructed case before deciding what to measure.

A referring team records Pharmacy First referrals as sent, while the pharmacy sees a mixture of completed consultations, unsuccessful contacts and appropriate onward routes. A shared report needs a stable referral denominator before the teams can interpret the difference.

Makes a shared operational problem inspectable without claiming that referral volume proves prevented readmissions.

What would we need to understand?

  • Defined referral source and cohort
  • Actual service availability and appropriate routing
  • Return or clarification categories
  • Staff work across referring and receiving teams

Constructed decision example | No customer results are shown.

NHS England (n.d.) | NHS England (n.d.)

Measure resolved coordination, not diverted demand.

Potential measures include correct identification of the next role, time to find the relevant local process, contradictions found and corrections required. A later governed service study might examine repeated contacts and patient understanding. It should not count every pharmacy consultation as a GP appointment saved: what would otherwise have happened needs evidence. Distinguish practice workload, pharmacy workload and the person's own effort. A pathway that transfers inconvenience to patients or pharmacies cannot claim system value merely because one queue becomes shorter.

Stop when the route becomes misleading.

The study should stop if the proposed brief uses outdated service information, implies clinical eligibility without assessment or leaves an important exception without a destination. Maintenance effort matters too. If keeping the information current requires more work than the existing route, the proposition needs redesign. An evaluation might conclude that a simpler agreement between teams is sufficient. That is a useful commissioning finding and a better basis for future investment than assuming every coordination problem needs another digital layer.

How a pathway earns its place.

Pallavi Dawda explains the development of Pharmacy First pathways in the original December 2023 webinar. A historical account of the approach, rather than current clinical instruction.

Community Pharmacy England | Uploaded 18 December 2023

Pallavi Dawda talks about the development of the Pharmacy First service clinical pathways and PGDs

Community Pharmacy England (2023) | 8 min 24 sec

Loads the YouTube player when you choose to watch.

Medicines context photograph | Source

Community Pharmacy England (2023) | Original film | Historical educational context

Current service guidance | Current Pharmacy First service documents

Published by Community Pharmacy England. Included as an external reference; no endorsement of NEUVIOR or PHARMORIS is implied.

Bring the exception your teams keep seeing.

A PCN manager, community pharmacy lead and commissioning representative can start with one recurring referral problem and the decision they need to make about it. We can discuss the smallest practical comparison and the evidence that would justify further development. The ambition is a pathway people can navigate with less uncertainty. PHARMORIS is being developed around that kind of organisational work; no service contract, integration or achieved workload reduction is implied by this proposed use case.

Another useful angle.

NEWSPerspectives & features